Phase I trial of lestaurtinib for children with refractory neuroblastoma: a new approaches to neuroblastoma therapy consortium study

PURPOSE: TrkB acts as an oncogenic kinase in a subset of human neuroblastomas. Lestaurtinib, a multi-kinase inhibitor with potent activity against Trk kinases, has demonstrated activity in preclinical models of neuroblastoma. METHODS: Patients with refractory high-risk neuroblastoma received lestaur...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Cancer Chemother Pharmacol
Autores principales: Minturn, Jane E., Evans, Audrey E., Villablanca, Judith G., Yanik, Gregory A., Park, Julie R., Shusterman, Suzanne, Groshen, Susan, Hellriegel, Edward T., Bensen-Kennedy, Debra, Matthay, Katherine K., Brodeur, Garrett M., Maris, John M.
Formato: Artigo
Lenguaje:Inglês
Publicado: 2011
Materias:
Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC4238911/
https://ncbi.nlm.nih.gov/pubmed/21340605
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00280-011-1581-4
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares